celecoxib has been researched along with Atheroma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, L | 1 |
| Li, J | 1 |
| Yi, J | 1 |
| Liu, H | 1 |
| Lei, H | 1 |
| Anwar, K | 1 |
| Voloshyna, I | 1 |
| Littlefield, MJ | 1 |
| Carsons, SE | 1 |
| Wirkowski, PA | 1 |
| Jaber, NL | 1 |
| Sohn, A | 1 |
| Eapen, S | 1 |
| Reiss, AB | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Impact of Anti-inflammatory Agents on Cholesterol Metabolism and Atherogenic Potency of Patient Plasma[NCT01279395] | 3 participants (Actual) | Observational | 2010-11-30 | Terminated (stopped due to Could not recruit adequate number of subjectsa) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for celecoxib and Atheroma
| Article | Year |
|---|---|
Dose-Effect of Irbesartan on Cyclooxygenase-2 and Matrix Metalloproteinase-9 Expression in Rabbit Atherosclerosis.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Aorta; Aortic Diseases; Atheroscle | 2018 |
COX-2 inhibition and inhibition of cytosolic phospholipase A2 increase CD36 expression and foam cell formation in THP-1 cells.
Topics: Arachidonic Acids; CD36 Antigens; Celecoxib; Cell Culture Techniques; Cells, Cultured; Cholesterol; | 2011 |